We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 27 DECEMBER 2018
A Tale Of Restasis: Misadventures Of Sovereign Immunity
Khurana & Khurana, Advocates and IP Attorneys
Allergan's "Restasis®" is a branded ophthalmic cyclosporine emulsion, for the treatment of chronic dry eye, with annual sales of nearly $1.5 billion.
IndiaIntellectual Property






